current or recent (within one week of surgery) systemic antibiotic use, intolerance to both clindamycin and cephalexin, discovery of a persistent cutaneous malignancy at the site of the defect following the reconstructive procedure and previous reconstruction at the site of the skin/soft-tissue defect.

NCT01912651_exc_T1
Drug
antibiotic
NCT01912651_exc_T2
Condition
intolerance
NCT01912651_exc_T3
Drug
clindamycin
NCT01912651_exc_T4
Drug
cephalexin
NCT01912651_exc_T5
Condition
persistent cutaneous malignancy
NCT01912651_exc_T6
Qualifier
site of the defect
NCT01912651_exc_T7
Temporal
following the reconstructive procedure
NCT01912651_exc_T8
Reference_point
the reconstructive procedure
NCT01912651_exc_T9
Procedure
reconstructive procedure
NCT01912651_exc_T10
Temporal
within one week of surgery
NCT01912651_exc_T11
Temporal
recent
NCT01912651_exc_T12
Temporal
current
NCT01912651_exc_T13
Scope
current or recent (within one week of surgery)
NCT01912651_exc_T14
Scope
antibiotic use, intolerance to both clindamycin and cephalexin, discovery of a persistent cutaneous malignancy at the site of the defect following the reconstructive procedure